{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:30:15Z","timestamp":1792845015299,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,30]]},"DOI":"10.7759\/cureus.65749","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:05:17Z","timestamp":1722351917000},"source":"Crossref","is-referenced-by-count":2,"title":["The Increased Frequency of Type 1 Regulatory T (Tr1) Cells and the Altered Expression of Aryl Hydrocarbon Receptor (AHR) and Interferon Regulatory Factor-4 (IRF4) Genes in Type 1 Diabetes: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Sameir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Soleimanifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Assadiasl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihad","family":"Selman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Mojtahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali J","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha H","family":"Abdulhussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa M","family":"Hamid Al-Gawwam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safin","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmalik F","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Nicknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/mi14010151","article-title":"Type 1 diabetes mellitus: a review on advances and challenges in creating insulin producing devices","volume":"14","author":"Rodrigues Oliveira SM","year":"2023","unstructured":"Rodrigues Oliveira SM, Rebocho A, Ahmadpour E, Nissapatorn V, de Lourdes Pereira M. Type 1 diabetes mellitus: a review on advances and challenges in creating insulin producing devices. Micromachines (Basel). 2023, 14:151. 10.3390\/mi14010151","journal-title":"Micromachines (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107842","article-title":"Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Patterson CC","year":"2019","unstructured":"Patterson CC, Karuranga S, Salpea P, Saeedi P, Dahlquist G, Soltesz G, Ogle GD. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019, 157:107842. 10.1016\/j.diabres.2019.107842","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032575","article-title":"Type 1 regulatory T cell-mediated tolerance in health and disease","volume":"13","author":"Freeborn RA","year":"2022","unstructured":"Freeborn RA, Strubbe S, Roncarolo MG. Type 1 regulatory T cell-mediated tolerance in health and disease. Front Immunol. 2022, 13:1032575. 10.3389\/fimmu.2022.1032575","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01510","article-title":"The AHR signaling attenuates autoimmune responses during the development of type 1 diabetes","volume":"11","author":"Yue T","year":"2020","unstructured":"Yue T, Sun F, Yang C, et al.. The AHR signaling attenuates autoimmune responses during the development of type 1 diabetes. Front Immunol. 2020, 11:1510. 10.3389\/fimmu.2020.01510","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15871","article-title":"ITK signalling via the Ras\/IRF4 pathway regulates the development and function of Tr1 cells","volume":"8","author":"Huang W","year":"2017","unstructured":"Huang W, Solouki S, Koylass N, Zheng SG, August A. ITK signalling via the Ras\/IRF4 pathway regulates the development and function of Tr1 cells. Nat Commun. 2017, 8:15871. 10.1038\/ncomms15871","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.07.004","article-title":"The emerging roles of AhR in physiology and immunity","volume":"86","author":"Hao N","year":"2013","unstructured":"Hao N, Whitelaw ML. The emerging roles of AhR in physiology and immunity. Biochem Pharmacol. 2013, 86:561-70. 10.1016\/j.bcp.2013.07.004","journal-title":"Biochem Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh L","year":"2010","unstructured":"Apetoh L, Quintana FJ, Pot C, et al.. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol. 2010, 11:854-61. 10.1038\/ni.1912","journal-title":"Nat Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403225","article-title":"Tr1 cells, but not Foxp3+ regulatory T cells, suppress NLRP3 inflammasome activation via an IL-10-dependent mechanism","volume":"195","author":"Yao Y","year":"2015","unstructured":"Yao Y, Vent-Schmidt J, McGeough MD, Wong M, Hoffman HM, Steiner TS, Levings MK. Tr1 cells, but not Foxp3+ regulatory T cells, suppress NLRP3 inflammasome activation via an IL-10-dependent mechanism. J Immunol. 2015, 195:488-97. 10.4049\/jimmunol.1403225","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2006","article-title":"The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells","volume":"12","author":"Cretney E","year":"2011","unstructured":"Cretney E, Xin A, Shi W, et al.. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol. 2011, 12:304-11. 10.1038\/ni.2006","journal-title":"Nat Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.5.1407","article-title":"Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes","volume":"54","author":"Brusko TM","year":"2005","unstructured":"Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes. 2005, 54:1407-14. 10.2337\/diabetes.54.5.1407","journal-title":"Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210839","article-title":"Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients","volume":"14","author":"Pellegrino M","year":"2019","unstructured":"Pellegrino M, Crin\u00f2 A, Rosado MM, Fierabracci A. Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients. PLoS One. 2019, 14:e0210839. 10.1371\/journal.pone.0210839","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-014-8440-0","article-title":"Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review","volume":"47","author":"Tan T","year":"2014","unstructured":"Tan T, Xiang Y, Chang C, Zhou Z. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. Clin Rev Allergy Immunol. 2014, 47:234-43. 10.1007\/s12016-014-8440-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2018026850","article-title":"Role of IL-10 receptor signaling in the function of CD4+ T-regulatory type 1 cells: T-cell therapy in patients with inflammatory bowel disease","volume":"38","author":"Soukou S","year":"2018","unstructured":"Soukou S, Brockmann L, Bedke T, Gagliani N, Flavell RA, Huber S. Role of IL-10 receptor signaling in the function of CD4+ T-regulatory type 1 cells: T-cell therapy in patients with inflammatory bowel disease. Crit Rev Immunol. 2018, 38:415-31. 10.1615\/CritRevImmunol.2018026850","journal-title":"Crit Rev Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197015","article-title":"Treg enhancing therapies to treat autoimmune diseases","volume":"21","author":"Eggenhuizen PJ","year":"2020","unstructured":"Eggenhuizen PJ, Ng BH, Ooi JD. Treg enhancing therapies to treat autoimmune diseases. Int J Mol Sci. 2020, 21:7015. 10.3390\/ijms21197015","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1697-y","article-title":"The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis","volume":"62","author":"Cai X","year":"2018","unstructured":"Cai X, Chen Y, Yang W, Gao X, Han X, Ji L. The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis. Endocrine. 2018, 62:299-306. 10.1007\/s12020-018-1697-y","journal-title":"Endocrine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0903-2","article-title":"Cigarette smoking, diabetes, and diabetes complications: call for urgent action","volume":"17","author":"Zhu P","year":"2017","unstructured":"Zhu P, Pan XF, Sheng L, Chen H, Pan A. Cigarette smoking, diabetes, and diabetes complications: call for urgent action. Curr Diab Rep. 2017, 17:78. 10.1007\/s11892-017-0903-2","journal-title":"Curr Diab Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00275","article-title":"Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells","volume":"3","author":"Kubo M","year":"2012","unstructured":"Kubo M, Motomura Y. Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells. Front Immunol. 2012, 3:275. 10.3389\/fimmu.2012.00275","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-018-0016-3","article-title":"Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus","volume":"42","author":"Gouda W","year":"2018","unstructured":"Gouda W, Mageed L, Abd El Dayem SM, Ashour E, Afify M. Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus. Bull Natl Res Cent. 2018, 42:1-6. 10.1186\/s42269-018-0016-3","journal-title":"Bull Natl Res Cent"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041120","article-title":"The relationship between type 1 diabetes mellitus, TNF-\u03b1, and IL-10 gene expression","volume":"11","author":"Dos Santos Haber JF","year":"2023","unstructured":"Dos Santos Haber JF, Barbalho SM, Sgarbi JA, et al.. The relationship between type 1 diabetes mellitus, TNF-\u03b1, and IL-10 gene expression. Biomedicines. 2023, 11:1120. 10.3390\/biomedicines11041120","journal-title":"Biomedicines"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.08.004","article-title":"Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"170","author":"Qiao YC","year":"2016","unstructured":"Qiao YC, Shen J, Hong XZ, Liang L, Bo CS, Sui Y, Zhao HL. Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Clin Immunol. 2016, 170:61-9. 10.1016\/j.clim.2016.08.004","journal-title":"Clin Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.11594\/jtls.07.03.15","article-title":"Correlation of interleukin-10, superoxide dismutase (SOD), and malondialdehyde (MDA) levels with HbA1c in pediatric type 1 diabetes mellitus","volume":"7","author":"Astari L","year":"2017","unstructured":"Astari L, Cahyono H, Widjajanto E. Correlation of interleukin-10, superoxide dismutase (SOD), and malondialdehyde (MDA) levels with HbA1c in pediatric type 1 diabetes mellitus. J Trop Life Sci. 2017, 7:286-92. 10.11594\/jtls.07.03.15","journal-title":"J Trop Life Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.02.002","article-title":"Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease","volume":"20","author":"Monteleone G","year":"2009","unstructured":"Monteleone G, Pallone F, Macdonald TT. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease. Cytokine Growth Factor Rev. 2009, 20:185-91. 10.1016\/j.cytogfr.2009.02.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.07.006","article-title":"Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes","volume":"84","author":"Ryd\u00e9n AK","year":"2017","unstructured":"Ryd\u00e9n AK, Perdue NR, Pagni PP, et al.. Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes. J Autoimmun. 2017, 84:65-74. 10.1016\/j.jaut.2017.07.006","journal-title":"J Autoimmun"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3509-8","article-title":"IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients","volume":"58","author":"Ferreira RC","year":"2015","unstructured":"Ferreira RC, Simons HZ, Thompson WS, et al.. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia. 2015, 58:781-90. 10.1007\/s00125-015-3509-8","journal-title":"Diabetologia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00397-7","article-title":"Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development","volume":"27","author":"Sayed TS","year":"2022","unstructured":"Sayed TS, Maayah ZH, Zeidan HA, Agouni A, Korashy HM. Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development. Cell Mol Biol Lett. 2022, 27:103. 10.1186\/s11658-022-00397-7","journal-title":"Cell Mol Biol Lett"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-014-9878-1","article-title":"Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes","volume":"37","author":"Ryba-Stanis\u0142awowska M","year":"2014","unstructured":"Ryba-Stanis\u0142awowska M, Rybarczyk-Kapturska K, My\u015bliwiec M, My\u015bliwska J. Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes. Inflammation. 2014, 37:1513-20. 10.1007\/s10753-014-9878-1","journal-title":"Inflammation"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/205284","article-title":"The serum IL-6 profile and Treg\/Th17 peripheral cell populations in patients with type 1 diabetes","volume":"2013","author":"Ryba-Stanis\u0142awowska M","year":"2013","unstructured":"Ryba-Stanis\u0142awowska M, Skrzypkowska M, My\u015bliwska J, My\u015bliwiec M. The serum IL-6 profile and Treg\/Th17 peripheral cell populations in patients with type 1 diabetes. Mediators Inflamm. 2013, 2013:205284. 10.1155\/2013\/205284","journal-title":"Mediators Inflamm"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12029","article-title":"Clinical application of regulatory T cells in type 1 diabetes","volume":"14","author":"Marek-Trzonkowska N","year":"2013","unstructured":"Marek-Trzonkowska N, My\u015bliwec M, Siebert J, Trzonkowski P. Clinical application of regulatory T cells in type 1 diabetes. Pediatr Diabetes. 2013, 14:322-32. 10.1111\/pedi.12029","journal-title":"Pediatr Diabetes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1248","article-title":"No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes","volume":"56","author":"Brusko T","year":"2007","unstructured":"Brusko T, Wasserfall C, McGrail K, et al.. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes. 2007, 56:604-12. 10.2337\/db06-1248","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02033","article-title":"Aryl hydrocarbon receptor promotes IL-10 expression in inflammatory macrophages through Src-STAT3 signaling pathway","volume":"9","author":"Zhu J","year":"2018","unstructured":"Zhu J, Luo L, Tian L, et al.. Aryl hydrocarbon receptor promotes IL-10 expression in inflammatory macrophages through Src-STAT3 signaling pathway. Front Immunol. 2018, 9:2033. 10.3389\/fimmu.2018.02033","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276842-the-increased-frequency-of-type-1-regulatory-t-tr1-cells-and-the-altered-expression-of-aryl-hydrocarbon-receptor-ahr-and-interferon-regulatory-factor-4-irf4-genes-in-type-1-diabetes-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:05:22Z","timestamp":1722351922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276842-the-increased-frequency-of-type-1-regulatory-t-tr1-cells-and-the-altered-expression-of-aryl-hydrocarbon-receptor-ahr-and-interferon-regulatory-factor-4-irf4-genes-in-type-1-diabetes-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.65749","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,30]]}}}